Open Access

Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)

  • Authors:
    • Fengfeng Cai
    • Manuel Antonio Falar Luis
    • Xiaoyan Lin
    • Minghong Wang
    • Lu Cai
    • Chunmei Cen
    • Ewelina Biskup
  • View Affiliations

  • Published online on: May 8, 2019     https://doi.org/10.3892/mco.2019.1854
  • Pages: 15-23
  • Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of malignancies. Cardiotoxicity is a well‑recognized side effect of anthracycline therapy that limits the total amount of drug administered and can cause heart failure in some patients. Most experimental data support oxidative stress as the etiology of anthracycline‑induced cardiotoxicity. The objective of this paper was to provide a review of the clinical classification, risk factors, monitoring and prevention of anthracycline‑induced cardiotoxicity in patients with breast cancer.
View Figures
View References

Related Articles

Journal Cover

July-2019
Volume 11 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cai F, Luis MA, Lin X, Wang M, Cai L, Cen C and Biskup E: Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review). Mol Clin Oncol 11: 15-23, 2019.
APA
Cai, F., Luis, M.A., Lin, X., Wang, M., Cai, L., Cen, C., & Biskup, E. (2019). Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review). Molecular and Clinical Oncology, 11, 15-23. https://doi.org/10.3892/mco.2019.1854
MLA
Cai, F., Luis, M. A., Lin, X., Wang, M., Cai, L., Cen, C., Biskup, E."Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)". Molecular and Clinical Oncology 11.1 (2019): 15-23.
Chicago
Cai, F., Luis, M. A., Lin, X., Wang, M., Cai, L., Cen, C., Biskup, E."Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)". Molecular and Clinical Oncology 11, no. 1 (2019): 15-23. https://doi.org/10.3892/mco.2019.1854